In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including legal challenges to the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, CMS, HHS, Medicare, drug prices
Source Links:
- Merck sues to block Medicare negotiation of drug prices
- Bristol Myers follows Merck's lead with its own lawsuit blasting IRA's Medicare negotiations
- PhRMA joins legal battle over Inflation Reduction Act's 'price-setting' measures
- Explaining the Prescription Drug Provisions in the Inflation Reduction Act
- Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026: Moody's
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Director
No transcript available.
POWERED BY BLUBRRY
